Cerlaz Oral Suspension 125 Mg/5 Ml & 250 Mg/5Ml 125 mg, 250 mg Powder for Oral Suspension
PDF Leaflet Revision Date: 06 October 2020
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of infections caused by susceptible micro-organisms.
Dosage (summary)
Adults: 250 mg every 6 hours; 1-4 g daily in divided doses.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; safety not established.
Key Drug Interactions
- Nephrotoxic agents
- Probenecid
- Metformin
- Oestrogen-containing contraceptives
Contraindications
- Allergy to cephalosporins
- Hypersensitivity to cephalexin
- Pregnancy
- Lactation
Common side effects
- Nausea
- Vomiting
- Diarrhoea
- Headache
- Dizziness
Counselling Points
- Take with or without food
- Monitor for allergic reactions
- Report severe diarrhoea
- Avoid driving if dizzy
Serious warnings
- Hypersensitivity reactions
- Pseudomembranous colitis
- Seizure potential
Important Disclaimer
The Cerlaz Oral Suspension 125 Mg/5 Ml & 250 Mg/5Ml 125 mg, 250 mg Powder for Oral Suspension professional information leaflet below is the property of Aurogen South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
